![Robert W. Kwiatkowski](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Robert W. Kwiatkowski
Nessuna posizione attualmente
Profilo
Robert W.
Kwiatkowski worked as Director-Assay Development at Third Wave Technologies, Inc. from 1996 to 2003.
He then worked as Vice President-Research & Development at Gentra Systems, Inc. and later as VP-Infectious Disease Research & Development at CEPHEID.
He holds a doctorate degree from The Johns Hopkins University.
Precedenti posizioni note di Robert W. Kwiatkowski
Società | Posizione | Fine |
---|---|---|
Third Wave Technologies, Inc.
![]() Third Wave Technologies, Inc. BiotechnologyHealth Technology Third Wave Technologies, Inc. developed DNA and RNA detection technology. It provided molecular solutions for clinical, research, and agricultural customers. The company was founded in February 1993 and was headquartered in Madison, WI. | Corporate Officer/Principal | 01/01/2003 |
CEPHEID | Corporate Officer/Principal | - |
Gentra Systems, Inc.
![]() Gentra Systems, Inc. Chemicals: Major DiversifiedProcess Industries Gentra Systems, Inc. develops and markets manual and automated nucleic acid purification products. It’s DNA and RNA purification products include Generation kits, Purescript, Autopure ls, and Versagene. The company was founded in 1988 by Ruth M. Shuman and is headquartered in Minneapolis, MN. | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Robert W. Kwiatkowski
The Johns Hopkins University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 3 |
---|---|
Gentra Systems, Inc.
![]() Gentra Systems, Inc. Chemicals: Major DiversifiedProcess Industries Gentra Systems, Inc. develops and markets manual and automated nucleic acid purification products. It’s DNA and RNA purification products include Generation kits, Purescript, Autopure ls, and Versagene. The company was founded in 1988 by Ruth M. Shuman and is headquartered in Minneapolis, MN. | Process Industries |
Third Wave Technologies, Inc.
![]() Third Wave Technologies, Inc. BiotechnologyHealth Technology Third Wave Technologies, Inc. developed DNA and RNA detection technology. It provided molecular solutions for clinical, research, and agricultural customers. The company was founded in February 1993 and was headquartered in Madison, WI. | Health Technology |
CEPHEID
![]() CEPHEID Medical SpecialtiesHealth Technology CEPHEID develops, manufactures and markets fully-integrated systems that perform genetic analysis. The firm's systems enable molecular testing for organisms and genetic-based diseases by automating otherwise complex manual laboratory procedures. The company was founded by Thomas L. Gutshall, William McMillan, Kurt Petersen, Greg Kovacs and M. Allen Northrup on March 4, 1996 and is headquartered in Sunnyvale, CA. | Health Technology |
- Borsa valori
- Insiders
- Robert W. Kwiatkowski